Company: CERO
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001213900-25-010230
Chunk: 383

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 383
---
 the common stockholders are entitled to vote. Holders of convertible preferred
stock and common stock vote together as a single class. Each holder of convertible preferred stock is entitled to the number of votes
equal to the number of shares of common stock into which the shares held by such holder are convertible.

Dividends – Dividends are payable
when and if declared by the board of directors (the “Board of Directors”), and preferred stockholders have preference over
common stockholders for the payment of dividends. The holders of Series Seed Preferred Stock and Series A Preferred Stock are
entitled to receive, when and if declared by the Board of Directors, noncumulative dividends at a rate of $ and $, respectively,
per share, per annum, adjustable for certain events, such as stock splits and combinations. No dividends have been declared or paid by
the Company to date.

F-61 CERo Therapeutics, Inc. Notes to Financial Statements Liquidation– Upon the occurrence of a liquidation, dissolution, or winding up of the Company, either voluntary or involuntary, the holders of Series A Preferred Stock then outstanding shall be entitled to be paid, out of the available funds and assets, and prior and in preference to any payment or distribution of any such funds on any shares of Series Seed Preferred Stock, and common stock, an amount per share equal to $ 1.7571, plus all declared but unpaid dividends. Upon the completion of the distribution described above, the holders of Series Seed Preferred Stock then outstanding shall be entitled to receive, out of the available funds and assets, in preference to any distribution of any of the assets to holders of common stock, an amount equal to the original issue price for such series of convertible preferred stock, $ 0.8059, plus any declared but unpaid dividends. Thereafter, any remaining proceeds shall be distributed among the holders of common stock pro rata based on the number of shares held by each such holder. Conversion– Each share of convertible preferred stock is convertible into common stock: (i) at the option of the holder; (ii) at the closing of an initial public offering of the Company’s common stock at a price not less than $ 3.5142per share and having aggregate cash proceeds of not less than $ 60,000,000; and (iii) at the date specified by written consent or agreement of the holders of at least 60% of the outstanding shares of Series A Preferred Stock, voting together as a single class. The conversion ratio for